Press releases

articles from November 2017

Orchard Therapeutics Announces Expansion of Technical Operations in California

Orchard Therapeutics, today announced the opening of a second facility for technical operations in the San Francisco Bay Area

Read more

Orchard Therapeutics announces extension of its collaboration with Manchester University to include Sanfilippo Syndrome type B

Orchard Therapeutics Limited, announces today that it has acquired an exclusive license to develop lentivirus-based autologous ex-vivo gene therapy for Sanfilippo syndrome type B (or MPS-IIIB) from The University of Manchester, UK

Read more